Oral Biologics & Biosimilar Drugs Global Market Report 2021: COVID 19 Growth And Change to 2030

Apr 2021| TBR769C| TBRC (Publisher)

Report Highlights

Including: 1) By Therapy: Lymphocyte Modulators; Interleukin Inhibitors; Tumor Necrosis Factor-Alpha Inhibitors
2) By Disease: Asthma; Crohn'S Disease; Carcinoma; Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Sarcoma; Psoriasis and Others
3) By Molecule Type: Vaccines; Proteins & Peptides; Monoclonal Antibodies; Others
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Covering: Novartis; Rani Therapeutics; Eli Lilly and Co.; AstraZeneca plc; Novo Nordisk A/S

Oral Biologics & Biosimilar Drugs Implants Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oral biologics & biosimilars market.

This report focuses on oral biologics & biosimilars market which is experiencing strong growth. The report gives a guide to the oral biologics & biosimilars market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the oral biologics & biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oral Biologics & Biosimilars Market market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider oral biologics & biosimilars market market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oral biologics & biosimilars market market section of the report gives context. It compares the oral biologics & biosimilars market market with other segments of the oral biologics & biosimilars market market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oral biologics & biosimilars market indicators comparison.

Scope

Markets Covered:1) By Therapy: Lymphocyte Modulators; Interleukin Inhibitors; Tumor Necrosis Factor-Alpha Inhibitors
2) By Disease: Asthma; Crohn'S Disease; Carcinoma; Arthritis; Diabetes; Multiple Myeloma; Enterocolitis; Multiple Sclerosis; Sarcoma; Psoriasis and Others
3) By Molecule Type: Vaccines; Proteins & Peptides; Monoclonal Antibodies; Others
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Novartis; Rani Therapeutics; Eli Lilly and Co.; AstraZeneca plc; Novo Nordisk A/S

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA; Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2 : Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3 : Global Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4 : Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5 : Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6 : Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7 : Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8 : Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9 : Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10 : China, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11 : India, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12 : Japan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13 : Australia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14 : Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15 : South Korea, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16 : Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17 : UK, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18 : Germany, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19 : France, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20 : Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21 : Russia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22 : North America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23 : USA, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24 : South America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25 : Brazil, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26 : Middle East, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27 : Africa, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28 : Novartis Financial Performance
  • Table 29 : Rani Therapeutics Financial Performance
  • Table 30 : Eli Lilly and Co. Financial Performance
  • Table 31 : AstraZeneca plc Financial Performance
  • Table 32 : Novo Nordisk A/S Financial Performance
  • Figure 1 : Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3 : Global Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4 : Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5 : Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6 : Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7 : Global Oral Biologics & Biosimilars Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8 : Global Oral Biologics & Biosimilars Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9 : Asia-Pacific, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10 : China, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11 : India, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12 : Japan, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13 : Australia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14 : Indonesia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15 : South Korea, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16 : Western Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17 : UK, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18 : Germany, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19 : France, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20 : Eastern Europe, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21 : Russia, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22 : North America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23 : USA, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24 : South America, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25 : Brazil, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26 : Middle East, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27 : Africa, Oral Biologics & Biosimilars Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28 : Novartis Financial Performance
  • Figure 29 : Rani Therapeutics Financial Performance
  • Figure 30 : Eli Lilly and Co. Financial Performance
  • Figure 31 : AstraZeneca plc Financial Performance
  • Figure 32 : Novo Nordisk A/S Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report